Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
General Biochemistry, Genetics and Molecular Biology
Reference45 articles.
1. Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer;Anagnostou;Cancer Res.,2019
2. Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer;Anagnostou;Nat. Cancer,2020
3. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma;Auslander;Nat. Med.,2018
4. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC;Camidge;Nat. Rev. Clin. Oncol.,2019
5. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients;Chabon;Nat. Commun.,2016
Cited by 190 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Peripheral B-cell levels predict efficacy and overall survival in advanced melanoma patients under PD-1 immunotherapy;Immunotherapy;2024-03
2. Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy;Cell Reports;2024-02
3. Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities;Cell Genomics;2024-01
4. Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non-small cell lung cancer;Journal for ImmunoTherapy of Cancer;2024-01
5. A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients;Cancer Immunology, Immunotherapy;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3